Studies a multimodal day hospital for adults with inflammatory bowel disease
Evaluates a combined day clinic service for adults with Crohn disease or ulcerative colitis.
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- Paris, FranceSee the site
- Trial code
- Registry title
- Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
- Status
- Not yet recruiting
- People taking part
- 240 people, planned
- Started
- Sept 2025
- Planned end
- Jul 2026
- Type of study
- Observational
- Record updated
- 11 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Crohn's disease or ulcerative colitis who are followed at Saint Antoine Hospital and are having a multimodal day hospital visit.
- Age
- Over 18 years
- Sex
- All
- Disease stage
- Ulcerative colitis or Crohn's disease for more than 3 months, with a diagnosis confirmed according to European guidelines
- Earlier treatment
- Must not have taken part before in an equivalent day hospital program
Main reasons for not taking part
- Protective measure in place
- Previous participation in an equivalent day hospital program
- Pregnant woman
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patient diagnosed with ulcerative colitis and Crohn's disease for more than 3 months, with a confirmed diagnosis according to European guidelines, being followed in the gastroenterology department at Saint Antoine Hospital
- Aged over 18 years
- Undergoing a multimodal day hospital visit, regardless of the scheduled intervention in the gastroenterology department at Saint Antoine Hospital
- Not opposed to participating in the research
Who cannot take part
- Patient who has previously participated in an equivalent day hospital program
- Protective measure in place
- Pregnant woman
Where in France
- Service de gastroentérologie Hôpital Saint AntoineParis, FranceContact: Paul Mclellan, DoctorNo longer taking part
About the trial
What the trial wants to find out
Inflammatory bowel diseases (IBD) are long-term conditions affecting more than 250,000 people in France. They typically begin in young adults and are characterized by flare-ups interspersed with periods of remission. The impact of these diseases goes beyond digestive symptoms, with fatigue present in 50 to 80% of cases. The overall effect on health leads to a decline in quality of life and work productivity. Therapeutic management relies on long-term immunosuppressive treatments aimed at inducing prolonged remission. While therapeutic management has become more complex with an increasing number of available treatments, evaluating the effectiveness and tolerance of these treatments requires a multimodal approach, including therapeutic education and specific follow-up based on the patient's profile and treatment, with the goal of comprehensive care and precision medicine.
Read full original descriptionShow less
Recently, multimodal day hospitalizations have been developed, particularly in response to the recent evolution of treatment administration routes toward subcutaneous or oral forms. In 2022, the gastroenterology and nutrition department of Saint Antoine Hospital, which follows 3,500 patients with CIBD, created a multimodal day hospital (DH) (four interventions) dedicated to patients treated with biologics and Janus kinase inhibitors. In a single session, this approach systematically combines (1) specific biological tests, especially pharmacokinetics, (2) a consultation with a gastroenterologist, (3) a consultation with a therapeutic education nurse, (4) and, depending on the identified needs of the patients, a dietary workshop or fatigue management session; a specialized dermatology or rheumatology consultation; and an ultrasound of the intestinal wall.
The goal of this study is to assess the benefits of a multimodal day hospital on the management and skills of patients with IBD.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
- Plain-language title
- Studies a multimodal day hospital for adults with inflammatory bowel diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 11 September 2025